Tissue Engineering and Regenerative Medicine

Jane Lebkowski has been actively involved in the development of cell and gene therapies since 1986 and is currently a Chief Scientific Officer and President of R&D at Asterias Biotherapeutics Inc, where she is responsible for all preclinical and product development of Asterias’ products. From 1998 to 2012, she was a Senior Vice President of Regenerative Medicine and Chief Scientific Officer at Geron Corporation. She led Geron’s human embryonic stem cell program, being responsible for all research, preclinical development, product development, manufacturing and clinical development activities. She has completed her PhD in Biochemistry from Princeton University in 1982 and completed a Post-doctoral Fellowship at the Department of Genetics, Stanford University in 1986. She has published over 70 peer reviewed papers and has 13 issued U.S. patents. She is on the Board of Directors of the American Society for Gene and Cell Therapy. She has served as an Industry Representative to FDA’s Office of Cell, Tissue and Gene Therapy Advisory Board.